Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Vasopressin agonist from Otsuka

Aug. 18, 1997

PharmaPrint submits IND for herbal BPH treatment

Aug. 18, 1997

New spironolactone formulation imparts improved bioavailability, clinical response

Aug. 13, 1997

TNP-470 for treatment of mesangial proliferative glomerulonephritis

Aug. 11, 1997

Medtronic's therapy for urinary incontinence recommended for approval by FDA panel

Aug. 8, 1997

Synsorb Biotech begins phase III trial for Synsorb Pk

July 25, 1997

FK-143: promising new BPH therapy

July 17, 1997

RPR launches room-temperature formulation of DDAVP

July 16, 1997

Selective alpha1a-adrenoceptor blockers described by Merck & Co.

July 10, 1997

Natural products for the treatment of BPH

July 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...